Evidence map›Paper›PMID 38863055›Full record

ReviewActas espanolas de psiquiatria2024

An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation.

Boyi Feng, Junli Zheng, Ying Cai, Yaguang Han, Yanhua Han, Jiaqi Wu, Jun Feng, Kai Zheng

Abstract readReview
In one paragraph

Review in Actas espanolas de psiquiatria, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. A comprehensive guide to genomeZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Biomarkers of cognitive and memory decline in psychotropic drug users.Journal of neural transmission (Vienna, Austria : 1996) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Boyi FengDepartment of Chronic Disease, Longhua District Center for Chronic Disease Control/Mental Health, 510080 Shenzhen, Guangdong, China; Shenzhen Guangming District People's Hospital, 518107 Shenzhen, Guangdong, China.
Junli ZhengDepartment of Chronic Disease, Longhua District Center for Chronic Disease Control/Mental Health, 510080 Shenzhen, Guangdong, China.
Ying CaiPublic Health Service Center, Bao'an District, 518100 Shenzhen, Guangdong, China.
Yaguang HanFirst Affiliated Hospital, Heilongjiang University of Chinese Medicine, 150000 Harbin, Heilongjiang, China.
Yanhua HanFirst Affiliated Hospital, Heilongjiang University of Chinese Medicine, 150000 Harbin, Heilongjiang, China.
Jiaqi WuDepartment of Chronic Disease, Longhua District Center for Chronic Disease Control/Mental Health, 510080 Shenzhen, Guangdong, China.
Jun FengDepartment of Chronic Disease, Longhua District Center for Chronic Disease Control/Mental Health, 510080 Shenzhen, Guangdong, China.
Kai ZhengDepartment of Chronic Disease, Longhua District Center for Chronic Disease Control/Mental Health, 510080 Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD), the most common form of dementia, has a complex pathogenesis. The number of AD patients has increased in recent years due to population aging, while a trend toward a younger age of onset has arisen, imposing a substantial burden on society and families, and garnering extensive attention. DNA methylation has recently been revealed to play an important role in AD onset and progression. DNA methylation is a critical mechanism regulating gene expression, and alterations in this mechanism dysregulate gene expression and disrupt important pathways, including oxidative stress responses, inflammatory reactions, and protein degradation processes, eventually resulting in disease. Studies have revealed widespread changes in AD patients' DNA methylation in the peripheral blood and brain tissues, affecting multiple signaling pathways and severely impacting neuronal cell and synaptic functions. This review summarizes the role of DNA methylation in the pathogenesis of AD, aiming to provide a theoretical basis for its early prevention and treatment.

Indexed as

Alzheimer DiseaseDNA MethylationEpigenesis, GeneticHumans

Identifiers

PMID38863055
PMCPMC11190457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.